Capstone Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,671
Closed -$290K 134
2025
Q4
$290K Buy
+11,671
New +$310K 0.28% 83

Other funds holding ASTH

Capstone Capital Management's ASTH Position: Q1 2026 in Review

Capstone Capital Management sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 11,671 shares — an estimated $290K sold.

Capstone Capital Management first reported a position in ASTH in Q4 2025 and held it in 1 quarter. The position peaked at $290K in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Capstone Capital Management reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
  • Capstone Capital Management sold 11,671 Astrana Health shares in Q1 2026, an estimated $290K.
  • Capstone Capital Management first reported a position in Astrana Health in Q4 2025 and held it in 1 quarter.
  • Capstone Capital Management's Astrana Health position peaked at $290K in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Capstone Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.